Standard and reference‐based conditional mean imputation-Reference-Cited by-同舟云学术

Standard and reference‐based conditional mean imputation

Published:2022-05-19 Issue:6 Volume:21 Page:1246-1257
ISSN:1539-1604
Container-title:Pharmaceutical Statistics
language:en
Short-container-title:Pharmaceutical Statistics

Author:

Wolbers Marcel¹^ORCID,Noci Alessandro¹,Delmar Paul¹,Gower‐Page Craig¹,Yiu Sean²,Bartlett Jonathan W.³

Affiliation:

1. Data and Statistical Sciences, Pharma Development Roche Basel Switzerland

2. Data and Statistical Sciences, Pharma Development Roche Welwyn Garden City UK

3. Department of Mathematical Sciences University of Bath Bath UK

Funder

Medical Research Council Canada

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pst.2234

Reference27 articles.

1. ICH E9 Working Group.ICH E9 (R1): Addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials;2019.https://database.ich.org/sites/default/files/E9‐R1_Step4_Guideline_2019_1203.pdf. Accessed May 16 2022.

2. Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials

3. Aligning Estimators With Estimands in Clinical Trials: Putting the ICH E9(R1) Guidelines Into Practice

4. Sensitivity analysis for clinical trials with missing continuous outcome data using controlled multiple imputation: A practical guide

5. Aligning Treatment Policy Estimands and Estimators—A Simulation Study in Alzheimer’s Disease

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applying the Estimand Framework to Non‐Inferiority Trials;Pharmaceutical Statistics;2024-08-08

2. Handling Partially Observed Trial Data After Treatment Withdrawal: Introducing Retrieved Dropout Reference‐Base Centred Multiple Imputation;Pharmaceutical Statistics;2024-07-16

3. Rejoinder to the letter: “Standard and reference‐based conditional mean imputation: Regulators and trial statisticians be aware!”;Pharmaceutical Statistics;2024-04-17

4. Comments on ‘standard and reference‐based conditional mean imputation’: Regulators and trial statisticians be aware!;Pharmaceutical Statistics;2024-04-17

5. Schema therapy versus treatment as usual for outpatients with difficult-to-treat depression: study protocol for a parallel group randomized clinical trial (DEPRE-ST);Trials;2024-04-16